ZA863382B - Quinolylglycinamide derivatives,the process for preparation thereof and their therapeutic application as psychotropic drugs - Google Patents
Quinolylglycinamide derivatives,the process for preparation thereof and their therapeutic application as psychotropic drugsInfo
- Publication number
- ZA863382B ZA863382B ZA863382A ZA863382A ZA863382B ZA 863382 B ZA863382 B ZA 863382B ZA 863382 A ZA863382 A ZA 863382A ZA 863382 A ZA863382 A ZA 863382A ZA 863382 B ZA863382 B ZA 863382B
- Authority
- ZA
- South Africa
- Prior art keywords
- quinolylglycinamide
- derivatives
- therapeutic application
- preparation
- psychotropic drugs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Quinoline Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8507247A FR2581382B1 (fr) | 1985-05-06 | 1985-05-06 | Derives n-(quinolyl) glycinamides, leur procede de preparation et leur application therapeutique en tant que psychotropes |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA863382B true ZA863382B (en) | 1987-01-28 |
Family
ID=9319228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA863382A ZA863382B (en) | 1985-05-06 | 1986-05-06 | Quinolylglycinamide derivatives,the process for preparation thereof and their therapeutic application as psychotropic drugs |
Country Status (16)
Country | Link |
---|---|
US (1) | US4788188A (xx) |
EP (1) | EP0205362B1 (xx) |
JP (1) | JPH0739395B2 (xx) |
KR (1) | KR860008982A (xx) |
AT (1) | ATE48835T1 (xx) |
AU (1) | AU582235B2 (xx) |
CA (1) | CA1263957A (xx) |
DE (1) | DE3667660D1 (xx) |
DK (1) | DK204686A (xx) |
ES (1) | ES8800161A1 (xx) |
FR (1) | FR2581382B1 (xx) |
GR (1) | GR861169B (xx) |
IL (1) | IL78691A (xx) |
NZ (1) | NZ216048A (xx) |
PT (1) | PT82512B (xx) |
ZA (1) | ZA863382B (xx) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8610981D0 (en) * | 1986-05-06 | 1986-06-11 | Ici America Inc | Quinoline amides |
GB8610980D0 (en) * | 1986-05-06 | 1986-06-11 | Ici America Inc | Heterocyclic fused tricyclic compounds |
DK273689A (da) * | 1988-06-06 | 1989-12-07 | Sanofi Sa | 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler |
FR2632861B1 (fr) * | 1988-06-15 | 1990-11-09 | Sanofi Sa | Derives d'amino-4 carboxy-3 quinoleines et naphtyridines, leur procede de preparation et leur application comme medicaments |
FR2632305B1 (fr) * | 1988-06-06 | 1992-05-15 | Sanofi Sa | Amino-4 aroyl-3 quinoleines et naphtyridines, leur procede de preparation et leur application en therapeutique |
FR2632639B1 (fr) * | 1988-06-09 | 1990-10-05 | Sanofi Sa | Derives d'amino-4 carboxy-3 naphtyridines, leur preparation et compositions pharmaceutiques qui les contiennent |
US5493027A (en) * | 1993-01-22 | 1996-02-20 | Board Of Regents, The University Of Texas System | Anticonvulsive agents and uses thereof |
US5783700A (en) * | 1997-07-03 | 1998-07-21 | Nichols; Alfred C. | Quinolic acid derivatives |
DE19960924C2 (de) * | 1999-12-17 | 2002-08-01 | Therapeutics Gmbh G.O.T. | Amphiphile Polyamine, deren Anwendungen |
DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
EP2392258B1 (en) | 2005-04-28 | 2014-10-08 | Proteus Digital Health, Inc. | Pharma-informatics system |
US8795627B2 (en) | 2007-03-21 | 2014-08-05 | Raptor Pharmaceuticals Inc. | Treatment of liver disorders by administration of RAP conjugates |
AU2010216512B2 (en) | 2009-02-20 | 2016-06-30 | 2-Bbb Medicines B.V. | Glutathione-based drug delivery system |
WO2010129819A2 (en) | 2009-05-06 | 2010-11-11 | Laboratory Skin Care, Inc. | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2456911A (en) * | 1945-05-04 | 1948-12-21 | Wyeth Corp | Disubstituted acetamidyl derivatives of amino quinolines |
US3470186A (en) * | 1967-06-02 | 1969-09-30 | American Cyanamid Co | Substituted 4-anilino-3-quinolinecarboxylic acids and esters |
GB1177548A (en) * | 1967-11-28 | 1970-01-14 | Ici Ltd | Phenoxy-and Anilino-Alkanoic Acid Amides |
FR8491M (xx) * | 1968-12-31 | 1973-07-27 | ||
US4789678A (en) * | 1986-08-25 | 1988-12-06 | Hoechst-Roussel Pharmaceuticals, Inc. | Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds |
-
1985
- 1985-05-06 FR FR8507247A patent/FR2581382B1/fr not_active Expired
-
1986
- 1986-04-24 ES ES554305A patent/ES8800161A1/es not_active Expired
- 1986-04-30 GR GR861169A patent/GR861169B/el unknown
- 1986-05-02 DK DK204686A patent/DK204686A/da not_active Application Discontinuation
- 1986-05-05 CA CA000508346A patent/CA1263957A/fr not_active Expired
- 1986-05-05 IL IL78691A patent/IL78691A/xx not_active IP Right Cessation
- 1986-05-05 NZ NZ216048A patent/NZ216048A/xx unknown
- 1986-05-05 PT PT82512A patent/PT82512B/pt not_active IP Right Cessation
- 1986-05-05 AU AU57142/86A patent/AU582235B2/en not_active Ceased
- 1986-05-06 AT AT86400973T patent/ATE48835T1/de not_active IP Right Cessation
- 1986-05-06 DE DE8686400973T patent/DE3667660D1/de not_active Expired - Fee Related
- 1986-05-06 ZA ZA863382A patent/ZA863382B/xx unknown
- 1986-05-06 KR KR1019860003557A patent/KR860008982A/ko not_active Application Discontinuation
- 1986-05-06 US US06/860,051 patent/US4788188A/en not_active Expired - Fee Related
- 1986-05-06 JP JP61103739A patent/JPH0739395B2/ja not_active Expired - Lifetime
- 1986-05-06 EP EP86400973A patent/EP0205362B1/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
JPS6226271A (ja) | 1987-02-04 |
KR860008982A (ko) | 1986-12-19 |
PT82512A (fr) | 1986-06-01 |
IL78691A (en) | 1989-09-28 |
AU582235B2 (en) | 1989-03-16 |
NZ216048A (en) | 1988-09-29 |
ES8800161A1 (es) | 1987-11-16 |
US4788188A (en) | 1988-11-29 |
ES554305A0 (es) | 1987-11-16 |
DK204686D0 (da) | 1986-05-02 |
GR861169B (en) | 1986-09-01 |
ATE48835T1 (de) | 1990-01-15 |
CA1263957A (fr) | 1989-12-19 |
FR2581382A1 (fr) | 1986-11-07 |
JPH0739395B2 (ja) | 1995-05-01 |
FR2581382B1 (fr) | 1987-06-26 |
AU5714286A (en) | 1987-11-12 |
EP0205362A1 (fr) | 1986-12-17 |
PT82512B (pt) | 1988-03-03 |
IL78691A0 (en) | 1986-08-31 |
EP0205362B1 (fr) | 1989-12-20 |
DK204686A (da) | 1986-11-07 |
DE3667660D1 (de) | 1990-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA895090B (en) | Novel benzopyran derivatives,processes for their preparation and their use and preparations containing the compounds | |
DE3366141D1 (en) | 1-phenylisoquinoline derivatives, process for their preparation, pharmaceutical compositions containing these compounds and their use | |
ZA863382B (en) | Quinolylglycinamide derivatives,the process for preparation thereof and their therapeutic application as psychotropic drugs | |
AU541976B2 (en) | Isoquinoline derivatives | |
ZA832044B (en) | Imidazolyphenyl-tetrahydropyridazines,processes for their preparation and pharmaceutical preparation containing them | |
PL288409A1 (en) | Method of obtaining novel derivatives of 4-phenyl-4-piperidinecarboxyamide | |
AU611113B2 (en) | Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds | |
HUT42770A (en) | Process for preparing novel pyrrolo-benzimidazole derivatives, pyrrolo -benzoxazole derivatives and pyrrolo-benzthiazole derivatives and pharmaceutical compositions comprising the same | |
PT84399A (en) | Process for the preparation of pharmaceutical compositions containing sodium 2-(2,6-dichloroanilino) phenylacetate | |
EP0086453A3 (en) | Thiazaspiro derivatives, process for their preparation and pharmaceutical composition | |
IE873212L (en) | Medicaments based on derivatives of 3,4-di-phenylpiperidine,¹the use of the derivatives as medicaments, and novel¹3,4-diphenylpiperidine derivatives and a process for the¹preparation therefor | |
ZA874470B (en) | New tetrahydrobenzothiazoles,and the preparation and use thereof | |
GR3006109T3 (xx) | ||
ES2027507A6 (es) | Procedimiento de preparacion de derivados selenofenicos. | |
DE3261643D1 (en) | New peptide, process for preparation thereof and use thereof | |
DE3469358D1 (en) | Novel 3-(4'-aminobutylamino)-propylamino-bleomycin derivatives, a process for their preparation and their use as medicaments |